States Want More Money and Less Punishment Over Opioids

Oregon Gov. Kate Brown

Oregon Gov. Kate Brown Jose Luis Magana / AP Photo

 

Connecting state and local government leaders

“To fully address the crisis we have to treat it as a health care issue, as a child welfare issue and as a drain on our local economies,” said U.S. Sen. Patty Murray of Washington state.

WASHINGTON — The governors of Maryland and Oregon asked senators Thursday to step up funding and coordination with states tackling the evolving opioid crisis, while rejecting a “punitive approach” to addiction.

Testifying before the Health, Education, Labor and Pensions Committee on Capitol Hill, Maryland Gov. Larry Hogan said nearly 2,000 people died from opioid overdoses in his state last year—more than firearm- and vehicle-related deaths combined.

Oregon Gov. Kate Brown illustrated the toll opioids were having on child welfare in her own state, where about 60 percent of kids in the foster care system have at least one parent with a substance abuse issue.

“Right now the federal government recognizes the problem but is focused on punishment,” Brown said. “That leaves us, the states, to right the wrongs of a war on drugs that has done nothing to address the issues that drive this public health crisis, while our prisons and our foster care systems are filled to capacity with its victims.”

The epidemic has affected almost every state, with the Centers for Disease Control and Prevention recently reporting a 30-percent increase in emergency room visits nationally for suspected opioid overdoses between July 2016 and September 2017. Data from 16 states hit hard by the crisis showed eight with increases in ER visits for suspected opioid overdoses of 25 percent or greater.

Maryland implemented a regional prescription drug monitoring program and limited the number of pills physicians could prescribe, only for heroin distribution to increase—followed by that of fentanyl and carfentanil. Addicts are killing themselves with a single use of fentanyl, which is also being used to lace cocaine in the state, and carfentanil is 50 to 100 times more deadly.

“I was the first governor in America to declare a real state of emergency on this issue because we decided that we needed to treat this crisis just like we would treat any other natural or manmade disaster,” Hogan said.

The Republican governor estimated Maryland has spent a half-billion dollars fighting the opioid epidemic. Fentanyl use was up about 70 percent in Maryland in 2017, trafficked in from China and Mexico, prompting Hogan to ask for more funding to track delivery services and for increased federal interdiction through the Stop Trafficking in Fentanyl Act, currently in the House of Representatives.

Brown, a Democrat, said Oregon would use any additional federal funds to get affordable, generic overdose drugs like naloxone, or Narcan, into the hands of all first responders and invest the remainder in behavioral health and substance abuse treatments. A prescription is no longer needed to get the drug over the counter in Maryland, per state law.

“States really are the ones that come up with the best ideas to tackle big problems because states are on the front lines,” said Sen. Lamar Alexander, a Tennessee Republican and the committee’s chairman. “It’s usually the federal government’s role to encourage them to cut the red tape and create an environment where states and communities can innovate.”

Hogan characterized himself as “a states’ rights guy,” like Alexander, but said more federal standards were needed for things like e-prescribing because states can’t control what’s occurring on the internet.

Meanwhile, Oregon’s governor wanted to see the federal government outline a more comprehensive approach to pain management and enable her state to make substance abuse treatment available to anyone in custody.

Oregon’s legislature recently passed a bill ensuring a “warm handoff” of patients with addictions from emergency rooms to peer mentors that can get them into treatment, and Brown will issue an executive order soon requiring a comprehensive strategic plan for treatment programs statewide.

“One of the challenges that we face in this arena is that the data, in terms of the physicians that are able to prescribe medically assisted treatment, that’s not available to the states,” Brown said. “It would be extremely useful if we could access that information.”

State and federal governments are starting to take a hard look at drug companies’ role in creating and sustaining the opioid crisis.

Massachusetts leads a bipartisan coalition of 41 states investigating drug manufacturers and distributors, said Democratic Sen. Elizabeth Warren, and more than 30 of her state’s cities and towns have launched lawsuits. Hogan said he’d directed Maryland’s attorney general to target pharmaceutical companies where appropriate, and the Justice Department also just started a Prescription Interdiction & Litigation Task Force.

Oregon was the first state to receive a settlement, north of $1 million, from drug maker Insys Therapeutics over deceptive marketing and payments made to sell an opioid. More than half that money went back into opioid treatment and recovery while a portion went to the Oregon Health and Science University, Brown said, advocating for a “case-by-case” approach to targeting CEOs where wrongdoing appears “egregious.”

“We have seen after far too long that we can’t simply treat this as a law enforcement issue,” said Sen. Patty Murray of Washington, the committee’s ranking Democrat. “To fully address the crisis we have to treat it as a health care issue, as a child welfare issue and as a drain on our local economies.”

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.